Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and
Families from across the UK returned to Westminster on Tuesday 5 November, clutching photos of their loved ones, along with stories and testimonies from dozens of patients who say they are thriving thanks to cannabis-based medicines.
PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals (“GW”;
THE UK’s Health Research Authority (HRA) has approved the country’s first clinical study using cannabis flower for the treatment of
THE typical patient at Sapphire Medical Clinics is a 65-year-old lady using cannabis medicine for chronic pain. This chimes with
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
